AdaptHealth Corp. (AHCO) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $13.21 (+0.76%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 26, 2026 | Whit Mayo | Leerink Partners | $12.00 | -9.2% |
| Feb 25, 2026 | Ben Hendrix | RBC Capital | $13.00 | -1.6% |
| Nov 15, 2024 | David MacDonald | Truist Financial | $12.00 | -9.2% |
| Nov 6, 2024 | Eric Coldwell | Robert W. Baird | $14.00 | +6.0% |
| Sep 23, 2024 | Eric Coldwell | Robert W. Baird | $16.00 | +21.1% |
| Aug 8, 2024 | Kevin Caliendo | UBS | $13.00 | -1.6% |
| Jul 26, 2022 | David MacDonald | Truist Financial | $24.00 | +81.7% |
Top Analysts Covering AHCO
AHCO vs Sector & Market
| Metric | AHCO | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 3 | 8 | 18 |
| Target Upside | -9.2% | +1150.3% | +14.9% |
| P/E Ratio | -24.87 | 6.89 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $3.44B | $3.46B | $3.48B | 6 |
| 2027-03-31 | $870M | $880M | $886M | 2 |
| 2027-06-30 | $901M | $912M | $918M | 2 |
| 2027-09-30 | $926M | $937M | $944M | 2 |
| 2027-12-31 | $981M | $993M | $1000M | 2 |
| 2028-03-31 | $930M | $942M | $948M | 1 |
| 2028-06-30 | $972M | $984M | $991M | 1 |
| 2028-09-30 | $1.00B | $1.01B | $1.02B | 1 |
| 2028-12-31 | $1.05B | $1.06B | $1.07B | 1 |
| 2029-12-31 | $5.46B | $5.51B | $5.56B | 2 |
| 2030-12-31 | $6.23B | $6.29B | $6.35B | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.97 | $1.00 | $1.02 | 4 |
| 2027-03-31 | $0.13 | $0.13 | $0.13 | 2 |
| 2027-06-30 | $0.30 | $0.30 | $0.30 | 1 |
| 2027-09-30 | $0.33 | $0.34 | $0.34 | 1 |
| 2027-12-31 | $0.44 | $0.45 | $0.45 | 2 |
| 2028-03-31 | $0.18 | $0.18 | $0.18 | 3 |
| 2028-06-30 | $0.43 | $0.43 | $0.44 | 2 |
| 2028-09-30 | $0.43 | $0.44 | $0.44 | 2 |
| 2028-12-31 | $0.50 | $0.51 | $0.52 | 3 |
| 2029-12-31 | $1.32 | $1.34 | $1.36 | 1 |
| 2030-12-31 | $1.52 | $1.54 | $1.56 | 1 |
Frequently Asked Questions
What is the analyst consensus for AHCO?
The consensus among 3 analysts covering AdaptHealth Corp. (AHCO) is Buy with an average price target of $12.50.
What is the highest price target for AHCO?
The highest price target for AHCO is $24.00, set by David MacDonald at Truist Financial on 2022-07-26.
What is the lowest price target for AHCO?
The lowest price target for AHCO is $12.00, set by David MacDonald at Truist Financial on 2024-11-15.
How many analysts cover AHCO?
3 analysts have issued ratings for AdaptHealth Corp. in the past 12 months.
Is AHCO a buy or sell right now?
Based on 3 analyst ratings, AHCO has a consensus rating of Buy (2.00/5) with a -9.2% upside to the consensus target of $12.50.
What are the earnings estimates for AHCO?
Analysts estimate AHCO will report EPS of $1.00 for the period ending 2026-12-31, with revenue estimated at $3.46B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.